Advertisement
UK markets close in 54 minutes
  • FTSE 100

    8,056.29
    +15.91 (+0.20%)
     
  • FTSE 250

    19,582.85
    -136.52 (-0.69%)
     
  • AIM

    752.75
    -1.94 (-0.26%)
     
  • GBP/EUR

    1.1659
    +0.0014 (+0.12%)
     
  • GBP/USD

    1.2499
    +0.0036 (+0.29%)
     
  • Bitcoin GBP

    50,853.57
    -1,269.12 (-2.43%)
     
  • CMC Crypto 200

    1,379.84
    -2.73 (-0.20%)
     
  • S&P 500

    5,006.23
    -65.40 (-1.29%)
     
  • DOW

    37,833.08
    -627.84 (-1.63%)
     
  • CRUDE OIL

    82.23
    -0.58 (-0.70%)
     
  • GOLD FUTURES

    2,337.80
    -0.60 (-0.03%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,868.47
    -220.23 (-1.22%)
     
  • CAC 40

    7,990.67
    -101.19 (-1.25%)
     

Gilead Sciences’ Valuation in December 2017

Gilead Sciences (GILD), a leading biopharmaceutical company headquartered in California, is involved in discovering, developing, and commercializing various innovative medicines.